Expression of CD44 splice variant v10 in Hodgkin's disease is associated with aggressive behaviour and high risk of relapse

Journal of Pathology

Volumn 186, Issue 4, 1998, Pages 383-389

  Beham Schmid, C ^a   Heider, K H ^b   Hoefler, G ^a   Zatloukal, K ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

Author keywords

CD44 isoforms; Hodgkin's disease; Immunohistochemistry; Prognosis; RT PCR

Indexed keywords

HERMES ANTIGEN;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; HIGH RISK POPULATION; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD44; ANTIGENS, NEOPLASM; HODGKIN DISEASE; HUMANS; IMMUNOENZYME TECHNIQUES; PROGNOSIS; PROTEIN ISOFORMS; RECURRENCE; REED-STERNBERG CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 0032414148     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199812)186:4<383::AID-PATH202>3.0.CO;2-A     Document Type: Article

References (51)

1. Haynes BF, Telen MJ, Hale LP, Denning SM. CD44 - a molecule involved in leukocyte adherence and T-cell activation. Immunol Today 1989; 10: 423-428.
2. Haynes BF, Liao HX, Patton KL. The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells 1991; 3: 347-350.
3. Lesley J, Hyman R, Kincade PW. CD44 and its interactions with the extracellular matrix. Adv Immunol 1993; 54: 271-335.
4. Günthert U. CD44: a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 1993; 184: 47-63.
5. Pals ST, Koopman G, Griffioen A, et al. CD44: a variety of isoforms with functions in cell adhesion and tumor metastasis. In: Shimiziu Y, ed. Lymphocyte Adhesion Molecules. Austin, TX: R. G. Landes, 1993; 135.
6. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Günthert U. Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 1994; 124: 71-82.
7. Dougherty GJ, Landorp PM, Cooper DL, Humphries RK. Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocytes 'homing' receptor expressed by hemopoietic cells. J Exp Med 1991; 174: 1-5.
8. Hofmann M, Rudy W, Zoller M, et al. CD44 splice variants confer metastatic behaviour in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 1991; 51: 5292-5297.
9. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992; 89: 12160-12164.
10. Tolg C, Hofmann M, Herrlich P, Ponta H. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 1993; 21: 1225-1229.
11. Heider KH, Hofmann M, Horst E, et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993; 120: 227-233.
12. Heider KH, Dämmrich J, Skroch-Angel P, et al. Differential expression of CD44 splice variants in intestinal- and diffuse type human gastric carcinomas and normal gastric mucosa. Cancer Res 1993; 53: 4197-4203.
13. Tarin D. Prognostic markers and mechanisms of metastasis. Rec Adv Histopathol 1997; 17: 15-45.
14. Rudy W, Hofmann M, Schwartz-Albiez R, et al. The two major CD44 proteins expressed on a rat metastatic tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res 1993; 53: 1262-1268.
15. Koopman G, Heider KH, Horst E, et al. Activated human lymphocytes and aggressive non-Hodgkin lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993; 177: 897-904.
16. Matsumura Y, Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992; 340: 1053-1058.
17. Wielenga VJ, Heider K, Offerhaus JA, et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor proaression. Cancer Res 1993; 53: 4754-4758.
18. Charpin C, Garcia S, Bouvier C, et al. Automated and quantitative immunohistochemical assays of CDv6 in breast carcinomas. Hum Pathol 1997; 28: 289-296.
19. Kaufmann M, Heider KH, Sinn HP, von-Minckwitz G, Ponta H, Herrlich P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995; 345: 615-619.
20. Mulder JWR, Kruyt PhM, Sewnath M, et al. Expression of exon v6 containing CD44 proteins in human colorectal cancer is associated with unfavourable prognosis in long term follow up. Lancet 1994; 344: 1470-1472.
21. Mueller W, Schneiders A, Heider KH, Meier S, Hommel G, Gappert HE. Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer. J Pathol 1997; 183: 222-227.
22. Horst E, Meijer CJ, Radaskiewicz T, et al. Expression of a human homing receptor (CD44) in lymphoid malignancies and related stages of lymphoid development. Leukemia 1990; 4: 383-389.
23. Jalkanen S, Joensuu H, Söderström KO, Klemi P. Lymphocyte homing and clinical behaviour of non-Hodakin's lymphoma. J Clin Invest 1991; 87: 1835-1840.
24. Möller P, Eichelmann A, Mechtersheimer G, Koretz K. Expression of beta1-integrins, H-CAM (CD44) and LECAM-1 in primary gut-intestinal B-cell lymphomas as compared to the adhesion receptor profile of the gut-associated lymphoid system, tonsil and peripheral lymph node. Int J Cancer 1991; 49: 846-855.
25. Picker LJ, Medeiros LJ, Weiss LM, Warnke RA, Butcher EC. Expression of lymphocyte homing receptor anticen in non-Hodgkin's lymphoma. Am J Pathol 1988; 130: 496-504.
26. Pals ST, Horst E, Ossekoppele GJ, Figdor CG, Scheper RJ, Meijer CJ. Expression of lymphocyte homing receptor as a mechanism of dissemination in non-Hodgkin's lymphoma. Blood 1989; 73: 885-888.
27. Fujiwara K, Yoshino T, Miyake K, Ohara N, Akagi T. Expression of a lymphocyte adhesion molecule (CD44) in malignant lymphomas: relevance to primary site, histological subtype and clinical stage. Acta Med Okayama 1993; 47: 215-222.
28. Terpe HJ, Stark H, Prehm P, Günthert U. CD44 variant isoforms are preferentially expressed in basal epithelia of non-malignant human fetal and adult tissues. Histochemistry 1994; 101: 79-89.
29. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860-1861.
30. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
31. Diehl V, Pfreundschuh M, Loffler M, et al. Cooperative trials of Hodgkin's lymphoma in the Federal Republic of Germany. J Cancer Res Clin Oncol 1990; 116: 106-108.
32. Pfreundschuh MG, Rueffer U, Lathan B, et al. Dexa-BEAM as salvage therapy for COPP+ABVD refractory Hodgkin's disease: a phase II study of the German Hodgkin study group. J Clin Oncol 1994; 12: 580-586.
33. Heider KH, Ratschek M, Zatloukal K, Adolf G. Expression of CD44-isoforms in human renal carcinomas. Virchows Arch 1996; 428: 267-273.
34. Gerdes J, Becker MHG, Hey G, Cattoretti G. Immunohistochemical detection of tumour growth fraction (Ki 67 antigen) in formalin-fixed and routinely processed tissues (Letter). J Pathol 1992; 168: 85-86.
35. Guesdon JL, Trenyn CKT, Avrameas S. The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 1979; 27: 1131-1139.
36. Cordell JI, Falini B, Erber WN, et al. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 219-229.
37. Günthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24.
38. Allen RW, Trach KA, Hoch JA. Identification of the 37-kDa protein displaying a variable interaction with the erythroid cell membrane as glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 1987; 262: 649-653.
39. Hofmann M, Rudy W, Zöller M, et al. CD44 splice variants confer metastatic behaviour in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 1991; 51: 5292-5297.
40. Stamenkovic I, Amiot M, Pesando JM, Seed B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilace link protein family. Cell 1989; 56: 1057-1062.
41. Ristamäki R, Joensuu H, Söderström KO, Jalkanen S. CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis. J Pathol 1995; 176: 259-267.
42. Terpe HJ, Stark H, Prehm P, Günthert U. CD44 variant isoforms are preferentially expressed in basal epithelia of non-malignant human fetal and adult tissues. Histochemistry 1994; 101: 79-89.
43. Horst E, Meijer CJLM, Radaskiewicz T, et al. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54). Leukemia 1990; 4: 595-599.
44. Stauder R, Eisterer W, Thaler J, Günthert U. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood 1995; 85: 2885-2899.
45. Picker LJ, Medeiros LJ, Weiss LM, Warnke RA, Butcher EC. Expression of lymphocyte homing receptor antigen in non-Hodgkin's lymphoma. Am J Pathol 1988; 130: 496-504.
46. Jalkanen S, Joensuu H, Klemi P. Prognostic value of lymphocyte homing receptor and S phase fraction in non-Hodgkin's lymphoma. Blood 1990; 75: 1549-1556.
47. Kansas GS, Muirhead MJ, Dailey MO. Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans. Blood 1990; 76: 2483-2493.
48. Joensuu H, Ristamäki R, Klemi PJ, Jalkanen S. Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma. Br J Cancer 1993; 68: 428-432.
49. Tarin D, Bolodeoku J, Hatfill SJ, Sugino T, Woodman AC, Yoshida K. The clinical significance of malfunction of the CD44 locus in malignancy. J Neuro-Oncol 1995; 26: 209-219.
50. Gorham H, Sugino T, Woodman AC, Tarin D. Cellular distribution of CD44 gene transcripts in colorectal carcinomas and in normal colonic mucosa. J Clin Pathol 1996; 49: 482-488.
51. Friedrichs K, Franke F, Lisboa BW, et al. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res 1995; 55: 5424-5433.